Home › Funds › Congress Small Cap Growth Fund
Fund family: PROFESSIONALLY MANAGED PORTFOLIOS · Filed by PROFESSIONALLY MANAGED PORTFOLIOS (CIK 811030) · SEC series S000058028
Share classes and tickers: CSMCX (C000189786), CSMVX (C000189785)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 382 with, 1 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 1 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other PROFESSIONALLY MANAGED PORTFOLIOS funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
The same votes as “with management” above, by the sector of the company voted on. 95.3% of this fund’s 383 such votes could be given a sector; the other 18 (4.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Industrials | 97 | 0 | 0.0% |
| Health Care | 80 | 0 | 0.0% |
| Consumer Discretionary | 69 | 1 | 1.4% |
| Technology | 55 | 0 | 0.0% |
| Finance | 37 | 0 | 0.0% |
| Miscellaneous | 22 | 0 | 0.0% |
| Real Estate | 5 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 279 | 0 |
| Audit-related | 43 | 0 |
| Say-on-Pay | 41 | 0 |
| Compensation | 11 | 0 |
| Capital Structure | 5 | 0 |
| Corporate Governance | 3 | 0 |
| Other | 2 | 0 |
| Shareholder Rights and Defenses | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | June 5, 2026 | $82M | 11 | 0 |
| TG THERAPEUTICS, INC. | June 11, 2026 | $82M | 8 | 0 |
| ACI WORLDWIDE, INC. | June 2, 2026 | $66M | 11 | 0 |
| UFP TECHNOLOGIES, INC. | June 4, 2026 | $63M | 9 | 0 |
| REPLIGEN CORPORATION | May 14, 2026 | $59M | 11 | 0 |
| INTERDIGITAL, INC. | June 10, 2026 | $55M | 11 | 0 |
| VERICEL CORPORATION | April 29, 2026 | $55M | 9 | 0 |
| ENPRO INC. | April 29, 2026 | $52M | 10 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 14, 2026 | CALIX, INC. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | Against | For |
385 ballot items at 41 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Congress Small Cap Growth Fund (CSMCX) voted at 41 shareholder meetings of 41 companies, on 385 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 1 time. Its most frequent area of disagreement was shareholder rights and defenses (1 of its votes against management). It voted on 1 shareholder proposal.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.